PhD Student Is Awarded for JMML Treatment Proposal

22 May 2015 2:43 AM | Anonymous
Congratulations to Chelsea Jenkins, a Ph.D. student, who was recently awarded $31,388 by Friends of Doernbecher for her proposal to develop novel treatments for children with Juvenile Myelomonocytic Leukemia (JMML). Friends of Doernbecher recently donated $175,000 to the Friends Grant program, which supports Doernbecher Children’s Hospital (DCH) faculty and staff with funding to pursue research or develop projects and programs at the hospital.


Doernbecher cares for the vast majority of children in Oregon with leukemia, which combined with the excellent research environment of the Knight Cancer Institute makes this an ideal place to develop and implement novel therapeutic strategies to improve outcomes for children with JMML.

For more information, click here.



This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode
standard for trustworthy health
 
information:  verify here.



Copyright (c) 2016 The JMML Foundation
Powered by Wild Apricot Membership Software